Provided by Tiger Trade Technology Pte. Ltd.

Regenxbio

10.72
-0.3400-3.07%
Post-market: 10.70-0.0200-0.19%19:30 EDT
Volume:1.01M
Turnover:10.87M
Market Cap:707.66M
PE:-2.85
High:11.16
Open:11.14
Low:10.49
Close:11.06
52wk High:16.19
52wk Low:5.46
Shares:66.01M
Float Shares:57.34M
Volume Ratio:1.11
T/O Rate:1.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7652
EPS(LYR):-3.7593
ROE:-137.63%
ROA:-21.20%
PB:9.86
PE(LYR):-2.85

Loading ...

Regenxbio presents long-term data for surabgene lomparvovec

TIPRANKS
·
Jul 19

Regenxbio Presents Positive Long-term Data for Surabgene Lomparvovec in Wet Amd and Diabetic Retinopathy at American Society of Retina Specialists Annual Meeting

THOMSON REUTERS
·
Jul 19

Regenxbio Reports 5-year Wet AMD Efficacy Data for Sura-vec Gene Therapy at ASRS Meeting

Reuters
·
Jul 19

Regenxbio Tumbles on Deep-discounted $100 Mln Equity Offering

Reuters
·
Jul 17

Top Premarket Decliners

MT Newswires Live
·
Jul 17

Regenxbio Prices 1,111,111 Pre-funded Warrants at USD 9 in Public Offering

Reuters
·
Jul 17

Regenxbio - Offering Expected to Close on July 20, 2026

THOMSON REUTERS
·
Jul 17

Regenxbio - Prices Public Offering of 10 Mln Shares at $9 and 1.11 Mln Pre-funded Warrants at $9

THOMSON REUTERS
·
Jul 17

Regenxbio - Expects Gross Proceeds of About $100 Mln from Offering

THOMSON REUTERS
·
Jul 17

Stocks to Watch: Netflix, Spacex, Alcoa, Regenxbio

Dow Jones
·
Jul 17

Regenxbio Slides on Plan to Offer $100M of Stock

Dow Jones
·
Jul 17

Regenxbio Shares Down 16.7% After the Bell; Announces Proposed $100 Mln Common Stock Public Offering

THOMSON REUTERS
·
Jul 17

REGENXBIO Announces Proposed $100 Million Public Stock Offering

MT Newswires Live
·
Jul 17

Regenxbio announces $100M common stock offering

TIPRANKS
·
Jul 17

Regenxbio Plans USD 100 Million Common Stock Offering to Raise Capital

Reuters
·
Jul 17

Regenxbio Announces Proposed Public Offering of Common Stock

THOMSON REUTERS
·
Jul 17

Regenxbio CMO Steve Pakola Sells 2,161 Shares Worth $29,479.04

Reuters
·
Jul 07

Regenxbio Chief Medical Officer Steve Pakola Sells USD 695,992 of Common Shares

Reuters
·
Jul 02

Regenxbio Shares Rise on $100M Milestone Payment After First Patient Dosed in Eye-disease Trial

Dow Jones
·
Jul 02

Regenxbio Rises on $100 Million Abbvie Milestone for Eye Disease Drug

Reuters
·
Jun 29